212 related articles for article (PubMed ID: 22338573)
1. Mechanisms of platelet activation in acute coronary syndromes.
Stakos DA; Tziakas DN; Stellos K
Curr Vasc Pharmacol; 2012 Sep; 10(5):578-88. PubMed ID: 22338573
[TBL] [Abstract][Full Text] [Related]
2. Novel antiplatelet therapy in acute coronary syndromes: what is new in the pipeline?
Müller KA; Geisler T
Curr Vasc Pharmacol; 2012 Sep; 10(5):606-18. PubMed ID: 22724478
[TBL] [Abstract][Full Text] [Related]
3. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.
Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD
Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147
[TBL] [Abstract][Full Text] [Related]
4. Oral antiplatelet agents in ACS: from pharmacology to clinical differences.
Agewall S; Badimon L; Drouet L; Eschenhagen T; Husted S; Simon T; Steg G
Fundam Clin Pharmacol; 2011 Oct; 25(5):564-71. PubMed ID: 21077944
[TBL] [Abstract][Full Text] [Related]
5. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study.
De Luca G; Secco GG; Iorio S; Verdoia M; Bellomo G; Marino P
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):756-9. PubMed ID: 23135381
[TBL] [Abstract][Full Text] [Related]
7. Novel antiplatelet therapy.
Gaglia MA; Manoukian SV; Waksman R
Am Heart J; 2010 Oct; 160(4):595-604. PubMed ID: 20934552
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet agents in acute coronary syndromes.
Sakhuja R; Yeh RW; Bhatt DL
Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
Passacquale G; Ferro A
Br J Clin Pharmacol; 2011 Oct; 72(4):604-18. PubMed ID: 21223359
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
11. The pharmacodynamics of antiplatelet compounds in thrombosis treatment.
Jayakumar T; Yang CH; Geraldine P; Yen TL; Sheu JR
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):615-32. PubMed ID: 27055051
[TBL] [Abstract][Full Text] [Related]
12. Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account.
Tantry US; Mahla E; Gesheff MG; Gurbel PA
Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1547-56. PubMed ID: 24147519
[TBL] [Abstract][Full Text] [Related]
13. Recent therapeutic approaches to platelet activation in coronary artery disease.
Tousoulis D; Paroutoglou IP; Papageorgiou N; Charakida M; Stefanadis C
Pharmacol Ther; 2010 Aug; 127(2):108-20. PubMed ID: 20546778
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of platelet reactivity. Clinical and pharmacodynamic effects.
Vallés J; Moscardo A; Madrid I; Santos MT
Curr Vasc Pharmacol; 2013 Jul; 11(4):431-47. PubMed ID: 23905638
[TBL] [Abstract][Full Text] [Related]
15. Novel Antiplatelet Agents: The Current State and What Is Coming Down the Pike.
Franchi F; Rollini F; Park Y; Angiolillo DJ
Prog Cardiovasc Dis; 2015; 58(3):267-77. PubMed ID: 26277706
[TBL] [Abstract][Full Text] [Related]
16. Emerging oral antiplatelet therapies for acute coronary syndromes.
Pollack CV
Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
[TBL] [Abstract][Full Text] [Related]
17. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
18. Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.
Koltai K; Kesmarky G; Feher G; Tibold A; Toth K
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820484
[TBL] [Abstract][Full Text] [Related]
19. Platelet reactivity on aspirin, clopidogrel and abciximab in patients with acute coronary syndromes and reduced estimated glomerular filtration rate.
Małek LA; Bilińska ZT; Sitkiewicz D; Kłopotowski M; Witkowski A; Ruzyłło W
Thromb Res; 2010 Jan; 125(1):67-71. PubMed ID: 19443019
[No Abstract] [Full Text] [Related]
20. Spontaneous platelet aggregation in patients with acute coronary syndrome.
Mazurov AV; Khaspekova SG; Yakushkin VV; Khachikyan MV; Zyuryaev IT; Ruda MY
Bull Exp Biol Med; 2013 May; 155(1):89-91. PubMed ID: 23667880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
